<?xml version="1.0"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
<channel>
<title>BloggingStocks</title>
<link>http://www.bloggingstocks.com</link>
<description>BloggingStocks</description>
<image>
<url>http://www.blogsmithmedia.com/http://www.bloggingstocks.com/media/feedlogo.gif</url>
<title>BloggingStocks</title>
<link>http://www.bloggingstocks.com</link>
</image>
<language>en-us</language>
<copyright>Copyright 2012 Weblogs, Inc. The contents of this feed are available for non-commercial use only.</copyright>
<generator>Blogsmith http://www.blogsmith.com/</generator><item><title><![CDATA[Market highlights for next week: RIMM to report Q2 earnings]]></title><link>http://www.bloggingstocks.com/2007/09/28/market-highlights-for-next-week-rimm-to-report-q2-earnings/</link><guid isPermaLink="true">http://www.bloggingstocks.com/2007/09/28/market-highlights-for-next-week-rimm-to-report-q2-earnings/</guid><comments>http://www.bloggingstocks.com/2007/09/28/market-highlights-for-next-week-rimm-to-report-q2-earnings/#comments</comments><description><![CDATA[<p>Filed under: <a href="http://www.bloggingstocks.com/category/earnings-reports/" rel="tag">Earnings Reports</a>, <a href="http://www.bloggingstocks.com/category/conventions-and-conferences/" rel="tag">Conventions and Conferences</a>, <a href="http://www.bloggingstocks.com/category/annual-meetings/" rel="tag">Annual Meetings</a>, <a href="http://www.bloggingstocks.com/category/gm/" rel="tag">General Motors (GM)</a>, <a href="http://www.bloggingstocks.com/category/bmy/" rel="tag">Bristol-Myers Squibb (BMY)</a>, <a href="http://www.bloggingstocks.com/category/rimm/" rel="tag">Research in Motion (RIMM)</a></p><a href="http://www.theflyonthewall.com/splashPage.php?source=AOL"><img vspace="4" hspace="4" border="1" align="right" alt="" src="http://www.blogcdn.com/www.bloggingstocks.com/media/2007/09/fly-logo-(aol).gif" /></a>Monday October 1<br /><br />* <a href="http://finance.aol.com/quotes/beijing-med-pharm-corporation/bjgp/nas">Beijing Med-Pharm Corporation</a> (NASDAQ: <a href="http://finance.aol.com/quotes/beijing-med-pharm-corporation/bjgp/nas">BJGP</a>) to hold a conference on the acquisition with Sunstone Pharma at 9am.<br /><br />Tuesday October 2<br /><br />* <a href="http://finance.aol.com/quotes/ford-motor-company/f/nys">Ford Motor Company</a> (NYSE: <a href="http://finance.aol.com/quotes/ford-motor-company/f/nys">F</a>) to report monthly sales at 1pm, <a href="http://finance.aol.com/quotes/general-motors-corporation/gm/nys">General Motors Corporation</a> (NYSE: <a href="http://finance.aol.com/quotes/general-motors-corporation/gm/nys">GM</a>) to report monthly sales at 2pm.<br />* PDUFA date for <a href="http://finance.aol.com/quotes/biovail-corporation/bvf/nys">Biovail Corporation</a> (NYSE: <a href="http://finance.aol.com/quotes/biovail-corporation/bvf/nys">BVF</a>)/<a href="http://finance.aol.com/quotes/depomed-inc/depo/nas">Depomed Inc</a> (NASDAQ: <a href="http://finance.aol.com/quotes/depomed-inc/depo/nas">DEPO</a>)/<a href="http://finance.aol.com/quotes/king-pharmaceuticals-inc/kg/nys">King Pharmaceutical Inc's</a> (NYSE: <a href="http://finance.aol.com/quotes/king-pharmaceuticals-inc/kg/nys">KG</a>) Glumetza for glycemic control in diabetic adults.<br /><br />Wednesday October 3<br /><br />* <a href="http://finance.aol.com/quotes/threshold-pharmaceuticals-inc/thld/nas">Threshold Pharmaceuticals</a> (NASDAQ: <a href="http://finance.aol.com/quotes/threshold-pharmaceuticals-inc/thld/nas">THLD</a>) to discuss Glufosfamide results from Phase III Clinical Trial at 4:30pm.<br /><br />Thursday October 4<br /><br />* <a href="http://finance.aol.com/quotes/constellation-brands-inc/stz/nys">Constellation Brands</a> (NYSE: <a href="http://finance.aol.com/quotes/constellation-brands-inc/stz/nys">STZ</a>) to report Q2 earnings; conference call at 10am.<br />* <a href="http://finance.aol.com/quotes/lawson-software-inc-new/lwsn/nas">Lawson Software</a> (NASDAQ: <a href="http://finance.aol.com/quotes/lawson-software-inc-new/lwsn/nas">LWSN</a>) to report Q1 earnings; conference call at 4:30pm.<br />* <a href="http://finance.aol.com/quotes/research-in-motion-limited/rimm/nas">Research In Motion</a> (NASDAQ: <a href="http://finance.aol.com/quotes/research-in-motion-limited/rimm/nas">RIMM</a>) to report Q2 earnings; conference call at 5pm.<br /><br />Friday October 5<br /><br />* PDUFA date for <a href="http://finance.aol.com/quotes/bristol-myers-squibb-company/bmy/nys">Bristol Myers Squibb's</a> (NYSE: <a href="http://finance.aol.com/quotes/bristol-myers-squibb-company/bmy/nys">BMY</a>) Abilify for the treatment of schizophrenia and manic episodes associated with Bipolar I Disorder.<p style="padding:5px;background:#ddd;border:1px solid #ccc;clear:both;"><a href="http://www.bloggingstocks.com/2007/09/28/market-highlights-for-next-week-rimm-to-report-q2-earnings/">Market highlights for next week: RIMM to report Q2 earnings</a> originally appeared on <a href="http://www.bloggingstocks.com">BloggingStocks</a> on Fri, 28 Sep 2007 15:30:00 EST.  Please see our <a href="http://www.weblogsinc.com/feed-terms/">terms for use of feeds</a>.</p><h6 style="clear: both; padding: 8px 0 0 0; height: 2px; font-size: 1px; border: 0; margin: 0; padding: 0;"></h6><a href="http://www.bloggingstocks.com/2007/09/28/market-highlights-for-next-week-rimm-to-report-q2-earnings/" rel="bookmark" title="Permanent link to this entry">Permalink</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/forward/1000721/" title="Send this entry to a friend via email">Email this</a>&nbsp;|&nbsp;<a href="http://www.bloggingstocks.com/2007/09/28/market-highlights-for-next-week-rimm-to-report-q2-earnings/#comments" title="View reader comments on this entry">Comments</a>]]></description><category>beijing med-pharma</category><category>BeijingMed-pharma</category><category>biovail</category><category>bjgp</category><category>bmy</category><category>bristol myers squibb</category><category>BristolMyersSquibb</category><category>bvf</category><category>conference</category><category>constellation brands</category><category>ConstellationBrands</category><category>depo</category><category>depomed</category><category>earnings</category><category>f</category><category>ford</category><category>general motors</category><category>GeneralMotors</category><category>Glufosfamide</category><category>glumetza</category><category>gm</category><category>highlight</category><category>inthenews</category><category>kg</category><category>king pharmaceutical</category><category>KingPharmaceutical</category><category>lawson</category><category>lwsn</category><category>pdufa</category><category>preview</category><category>research in motion</category><category>ResearchInMotion</category><category>rimm</category><category>sales</category><category>stz</category><category>thld</category><category>threshold</category><dc:creator><![CDATA[Eric Buscemi]]></dc:creator><pubDate>Fri, 28 Sep 2007 15:30:00 EST</pubDate></item></channel></rss>
